Read on the application
Share price of Jubilant Pharmava (Jubilant Life Sciences Ltd) rose by nearly 7 percent today. After which the share of the company reached the level of Rs 439.80 in BSE. However, the company’s shares were down at the market close. The company’s share price closed at Rs 413.75 on BSE on Monday.
80 rupees a share, 100 rupees profit, GMP proud
Why did it accelerate?
The company said in a disclosure to the stock markets that its radiopharma business has received ANDA approval for technetium sulfur colloid injection. This approval will be effective from 9 November 2023.
Increase the company’s revenue
The second quarter has proved to be excellent for the company. The company told the bourses that revenue rose 5 percent year-on-year. This time the income has been 1680 crore rupees. The company’s radiopharma business revenue has seen an increase of 12.61 percent. This time the income of this department of the company is 741 crore rupees.
Also Read: The company is paying a dividend of Rs 20 per share on record date today
Jubilant Pharma’s share price has seen an increase of over 21 percent in the last 6 months. At the same time, the company’s share price has increased by more than 6 percent over the past year.